Edmund Harrigan Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

Edmund Harrigan is of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 25,654 shares of ACAD, which is worth approximately $440,479. The most recent transaction as insider was on May 29, 2024, when has been sold 6,652 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.7K
0% 3M change
35.01% 12M change
Total Value Held $440,479

EDMUND HARRIGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
BUY
Exercise of conversion of derivative security
-
6,652 Added 20.59%
25,654 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
8,552 Added 31.04%
19,002 Common Stock
Jun 07 2022
BUY
Exercise of conversion of derivative security
-
6,391 Added 37.95%
10,450 Common Stock
Jun 22 2021
BUY
Exercise of conversion of derivative security
-
3,059 Added 42.98%
4,059 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
Director
PHAS
PhaseBio Pharmaceuticals Inc Healthcare
Director
EH

Edmund Harrigan

Wilmington, DE

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD